(CABA) Cabaletta Bio - Performance -90% in 12m
Compare CABA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-68.60%
#97 in Group
Rel. Strength
1.43%
#7843 in Universe
Total Return 12m
-89.98%
#190 in Group
Total Return 5y
-84.20%
#93 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
33th Percentile in Group
12m Total Return: CABA (-90%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CABA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CABA
Total Return (including Dividends) | CABA | XBI | S&P 500 |
---|---|---|---|
1 Month | 16.35% | 11.81% | 13.81% |
3 Months | -52.17% | -13.61% | -6.30% |
12 Months | -89.98% | -12.29% | 10.65% |
5 Years | -84.20% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | CABA | XBI | S&P 500 |
1 Month | 45.2% | 72.9% | 83% |
3 Months | -86.8% | -83% | -75.3% |
12 Months | -97.2% | -51.6% | 50.1% |
5 Years | -14.3% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #89 | 4.06% | 2.23% |
3 Month | #175 | -44.6% | -49.0% |
12 Month | #191 | -88.6% | -91.0% |
5 Years | #94 | -79.0% | -92.4% |
FAQs
Does CABA Cabaletta Bio outperforms the market?
No,
over the last 12 months CABA made -89.98%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CABA made -52.17%, while XBI made -13.61%.
Over the last 3 months CABA made -52.17%, while XBI made -13.61%.
Performance Comparison CABA vs Indeces and Sectors
CABA vs. Indices CABA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -4.38% | 2.54% | -68.1% | -101% |
US NASDAQ 100 | QQQ | -4.57% | -1.01% | -68.3% | -102% |
US Dow Jones Industrial 30 | DIA | -4.79% | 6.36% | -67.8% | -97.7% |
German DAX 40 | DAX | -4.36% | 1.39% | -94.4% | -116% |
Shanghai Shenzhen CSI 300 | CSI 300 | -6.56% | 4.52% | -68.9% | -97.4% |
Hongkong Hang Seng | HSI | -7.55% | -3.58% | -76.5% | -104% |
India NIFTY 50 | INDA | 0.54% | 11.5% | -68.6% | -89.8% |
Brasil Bovespa | EWZ | -5.43% | -0.89% | -76.8% | -81.7% |
CABA vs. Sectors CABA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.02% | 2.94% | -75.2% | -112% |
Consumer Discretionary | XLY | -4.76% | 2.12% | -67.1% | -104% |
Consumer Staples | XLP | -3.52% | 9.76% | -75.0% | -99.1% |
Energy | XLE | -4.20% | 9.59% | -61.5% | -80.5% |
Financial | XLF | -5.48% | 2.83% | -75.2% | -112% |
Health Care | XLV | -1.37% | 15.5% | -63.1% | -85.9% |
Industrial | XLI | -6.07% | -0.47% | -69.5% | -101% |
Materials | XLB | -4.18% | 2.79% | -63.2% | -84.8% |
Real Estate | XLRE | -3.06% | 4.81% | -68.9% | -105% |
Technology | XLK | -5.46% | -4.87% | -65.2% | -97.1% |
Utilities | XLU | -4.43% | 6.76% | -75.8% | -107% |
Aerospace & Defense | XAR | -6.36% | -4.81% | -79.6% | -117% |
Biotech | XBI | 2.21% | 4.54% | -48.0% | -77.7% |
Homebuilder | XHB | -4.85% | 4.87% | -54.9% | -82.4% |
Retail | XRT | -6.28% | 1.70% | -63.9% | -88.5% |